SCHEMBL4570728

SCHEMBL4570728

CC(C)(C)N1CCC(C)(S(=O)(=O)c2ccc(Cl)cc2)C1=O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EEF2K O00418 1/20 0.45
MAPT P10636 2/20 0.41
PSEN1 P49768 4/20 0.38
PSEN2 P49810 4/20 0.38
APH1B Q8WW43 4/20 0.38
NCSTN Q92542 4/20 0.38
APH1A Q96BI3 4/20 0.38
PSENEN Q9NZ42 4/20 0.38
KMT2A Q03164 2/20 0.37
ATM Q13315 1/20 0.37
SMN1; SMN2 Q16637 4/20 0.37
TDP1 Q9NUW8 1/20 0.36
LMNA P02545 4/20 0.36
HTT P42858 3/20 0.36
ALDH1A1 P00352 3/20 0.36
GAA P10253 2/20 0.36
NPSR1 Q6W5P4 2/20 0.36
MMP1 P03956 1/20 0.36
MMP9 P14780 1/20 0.36
MMP13 P45452 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1785466 0.73 CNR2 (0.36) EEF2KMAPTPSEN1PSEN2APH1B
SCHEMBL4570737 0.73 CNR2 (0.36) EEF2KMAPTPSEN1PSEN2APH1B
SCHEMBL4570738 0.73 CNR2 (0.36) EEF2KMAPTPSEN1PSEN2APH1B
SCHEMBL1787389 0.72 CNR2 (0.43) EEF2KMAPTPSEN1PSEN2APH1B
SCHEMBL1783083 0.71 EEF2K (0.50) EEF2KMAPTPSEN1PSEN2APH1B
SCHEMBL4570735 0.70 L3MBTL1 (0.50) MAPTSMN1; SMN2TDP1ALDH1A1GAA
SCHEMBL8238205 0.66 EEF2K (0.44) EEF2KMAPTPSEN1PSEN2APH1B
SCHEMBL17689397 0.65 EEF2K (0.60) EEF2KPSEN1PSEN2APH1BNCSTN
SCHEMBL2760213 0.65 EEF2K (0.60) EEF2KPSEN1PSEN2APH1BNCSTN
SCHEMBL14227519 0.65 EEF2K (0.55) EEF2KMAPTPSEN1PSEN2APH1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8178568-B2 Sulfone compounds which modulate the CB2 receptor BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-05-15 US disclosed
US-20110124696-A1 Sulfone Compounds Which Modulate The CB2 Receptor BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2011-05-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110124696-A1 Sulfone Compounds Which Modulate The CB2 Receptor CNR2, CNR1, TRPV1 EEF2K 1998/4885MAPT 3897/4885PSEN1 3307/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.